Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept in Systemic Sclerosis
NCT01538719Phase 2Completed
- Sponsor
- Boston University
- Start
- Dec 2011
- Primary completion
- Jan 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in systemic sclerosis (SSc), sponsored by Boston University. Started Dec 2011; status: completed.
02
Drugs
rilonacept
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01538719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538719.